Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Goodwill (2017 - 2026)

Organogenesis Holdings has reported Goodwill over the past 9 years, most recently at $28.8 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $28.8 million; the TTM value through Dec 2025 reached $28.8 million, changed 0.0%, while the annual FY2025 figure was $28.8 million, 0.0% changed from the prior year.
  • Goodwill for Q4 2025 was $28.8 million at Organogenesis Holdings, roughly flat from $28.8 million in the prior quarter.
  • Over five years, Goodwill peaked at $28.8 million in Q1 2021 and troughed at $28.8 million in Q1 2021.
  • A 5-year average of $28.8 million and a median of $28.8 million in 2021 define the central range for Goodwill.
  • On a YoY basis, Goodwill climbed as much as 12.66% in 2021 and fell as far as 0.5% in 2021.
  • Year by year, Goodwill stood at $28.8 million in 2021, then changed by 0.0% to $28.8 million in 2022, then changed by 0.0% to $28.8 million in 2023, then changed by 0.0% to $28.8 million in 2024, then changed by 0.0% to $28.8 million in 2025.
  • Business Quant data shows Goodwill for ORGO at $28.8 million in Q4 2025, $28.8 million in Q3 2025, and $28.8 million in Q2 2025.